Drugs Made In America Acquisition II Corp
DMII
51 hedge funds and large institutions have $343M invested in Drugs Made In America Acquisition II Corp in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
54.51% more ownership
Funds ownership: 0% → 54.51% (+55%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$26.7M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$23.2M |
| 3 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$20.4M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$19.5M |
| 5 |
Millennium Management
New York
|
+$14.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Morgan Stanley
New York
| $1.67K | +$1.67K | +169 | New |
|
DMII Hedge Fund Activity: Q4 2025 in Review
51 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp (DMII) for Q4 2025, worth a combined $343M.
Buyers outnumbered sellers: 51 funds opened new DMII positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $26.7M.
- 51 institutional investors held Drugs Made In America Acquisition II Corp (DMII) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $343M of Drugs Made In America Acquisition II Corp stock for Q4 2025.
- 51 funds opened new Drugs Made In America Acquisition II Corp positions in Q4 2025 and 0 closed out, a net change of +51 holders.
- The largest Drugs Made In America Acquisition II Corp buyer in Q4 2025 was Magnetar Financial, an estimated $26.7M added.
Based on aggregated 13F filings for Q4 2025.